The Centers for Medicare & Medicaid Services has delayed 2020 private payer data reporting for the Clinical Diagnostic Test Payment System until 2021 for tests that are not advanced diagnostic laboratory tests, as required by recent legislation extending funding for federal programs through fiscal year 2020. Under the legislation, applicable laboratories, including hospital outreach laboratories, that were to report data between Jan. 1 and March 31, 2020, will instead report the data between Jan. 1, 2021, and March 31, 2021. Data reporting then will resume on a three-year cycle beginning in 2024. In addition, CMS may not reduce 2020 payment rates for clinical diagnostic laboratory tests that are not advanced or new tests by more than 10% in 2020 and by more than 15% per year in 2021, 2022 or 2023. Congress also directed the Medicare Payment Advisory Commission to study and report within 18 months on the least burdensome data collection process that would lead to a “representative and statistically valid data sample of private market rates from all laboratory segments,” including hospital outreach laboratories. The study will consider the variability of private market rates and the appropriate statistical methods for estimating representative rates. 
 

Headline
Most hospital outreach laboratories have until July 31 to report required private payer clinical diagnostic laboratory data for services furnished during the…
Headline
The Trusted Exchange Framework and Common Agreement Recognized Coordinating Entity published updated standard operating procedures for the individual access…
Headline
The Centers for Medicare & Medicaid Services July 1 launched the Medicare GLP-1 Bridge, a short-term demonstration program designed to provide eligible…
Headline
A blog by Noah Isserman, AHA director of health insurance and coverage policy, explains why a recent analysis by the Medicare Payment Advisory Commission…
Blog
Public
Medicare Advantage now covers more than half of eligible Medicare beneficiaries, making its impact on hospitals, health systems and patients impossible to…
Headline
The House Energy and Commerce Subcommittee on Health June 25 held a markup session on bills regarding healthcare price transparency, illicit drugs …